Evidence map›Paper›PMID 19773542›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2009

Effect of rifampin and nelfinavir on the metabolism of methadone and buprenorphine in primary cultures of human hepatocytes.

David E Moody, Wenfang B Fang, Shen-Nan Lin, Denise M Weyant, Stephen C Strom, Curtis J Omiecinski

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.8field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

David E MoodyCenter for Human Toxicology, Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84108, USA. david.moody@utah.edu
Wenfang B Fang
Shen-Nan Lin
Denise M Weyant
Stephen C Strom
Curtis J Omiecinski
University of Utah · US

Funding

Targeting Dynamics of CAR and PXR in the Mouse and Human GenomesR01GM066411 · NIGMS · PENNSYLVANIA STATE UNIVERSITY-UNIV PARK · PI OMIECINSKI, CURTIS J · 2002 to 2017
$4.5M
Human Metabolism of Anti-Abuse MedicationsR01DA010100 · NIDA · UNIVERSITY OF UTAH · PI MOODY, DAVID E · 1997 to 2005
$750k
INVESTIGATIVE ENDOCRINOLOGYT32DK007004 · NIDDK · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI SURKS, MARTIN I · 1986 to 1994
–
NIDA NIH HHS R01 DA010100NIDA NIH HHS R01-DA10100NIDDK NIH HHS N01-DK-7-004NIGMS NIH HHS GM066411NIGMS NIH HHS R01 GM066411NLM NIH HHS HHSN267200700004CNLM NIH HHS HHSN267200700004G
6 · The paper itself

Abstract

We tested the hypothesis that primary cultures of human hepatocytes could predict potential drug interactions with methadone and buprenorphine. Hepatocytes (five donors) were preincubated with dimethyl sulfoxide (DMSO) (vehicle), rifampin, or nelfinavir before incubation with methadone or buprenorphine. Culture media (0-60 min) was analyzed by liquid chromatography-tandem mass spectrometry for R- and S-methadone and R- and S-2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidine (EDDP) or for buprenorphine, norbuprenorphine, and their glucuronides [buprenorphine-3-glucuronide (B-3-G) and norbuprenorphine-3-glucuronide (N-3-G)]. R- and S-EDDP were detected in three of five, four of five, and five of five media from cells pretreated with DMSO, nelfinavir, and rifampin. R-EDDP increased 3.1- and 26.5-fold, and S-EDDP increased 2.5- and 21.3-fold after nelfinavir and rifampin. The rifampin effect was significant. B-3-G production was detected in media of all cells incubated with buprenorphine and accounted for most of the buprenorphine loss from culture media; it was not significantly affected by either pretreatment. Norbuprenorphine and N-3-G together were detected in three of five, four of five, and five of five donors pretreated with DMSO, nelfinavir and rifampin, and norbuprenorphine in one of five, one of five, and two of five donors. Although there was a trend for norbuprenorphine (2.8- and 4.9-fold) and N-3-G (1.7- and 1.9-fold) to increase after nelfinavir and rifampin, none of the changes were significant. To investigate low norbuprenorphine production, buprenorphine was incubated with human liver and small intestine microsomes fortified to support both N-dealkylation and glucuronidation; N-dealkylation predominated in small intestine and glucuronidation in liver microsomes. These studies support the hypothesis that methadone metabolism and its potential for drug interactions can be predicted with cultured human hepatocytes, but for buprenorphine the combined effects of hepatic and small intestinal metabolism are probably involved.

Indexed as

AdultAgedAnalgesics, OpioidAntibiotics, AntitubercularBiotransformationBuprenorphineCells, CulturedChromatography, LiquidDealkylationDrug InteractionsFemaleGlucuronidesHepatocytesHIV Protease InhibitorsHumansIntestinal Mucosa2-ethylidene-1,5-dimethyl-3,3-diphenylpyrrolidineAnalgesics, OpioidAntibiotics, AntitubercularBuprenorphinebuprenorphine-3-O-glucuronideGlucuronidesHIV Protease InhibitorsMethadoneNelfinavirnorbuprenorphinenorbuprenorphine-3-beta-D-glucuronidePyrrolidinesRifampin

Identifiers

PMID19773542
PMCPMC2784702
OpenAlexW2096209099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.